Genetically Modified T-cell Therapy for the Treatment of Osteosarcoma: An Update.
Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, Texas 77030, USA; Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Pediatrics Baylor College of Medicine, Houston, Texas 77030, USA.
Christopher
C
DeRenzo
Center for Cell and Gene Therapy, Texas Children's Hospital, Houston Methodist Hospital, Baylor College of Medicine, Houston, Texas 77030, USA; Texas Children's Cancer Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas 77030, USA; Department of Pediatrics Baylor College of Medicine, Houston, Texas 77030, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas 77030, USA.
Stephen
S
Gottschalk
Cancer immunotherapy; Chimeric antigen receptors; Gene therapy; Osteosarcoma; Pediatric cancer; T-cell therapy; Tumor antigens